2018
DOI: 10.1177/1359105318756500
|View full text |Cite
|
Sign up to set email alerts
|

Project reach: Piloting a risk-tailored smoking cessation intervention for lung screening

Abstract: The purpose of this study was to explore the feasibility, acceptability, and efficacy of a telephone-based smoking cessation intervention for lung screening patients. Participants ( N = 39) were enrolled in a single-arm pilot study of a four-session telephone-based intervention. Self-report measures were completed at baseline, post-intervention, and 3-month follow-up. Participants were long-term smokers; 62 percent were not motivated to quit. Twenty-three percent attempted quitting, 29 percent decreased their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…After the National Lung Screening Trial (NLST) findings in 2011 showed a substantial relative reduction in lung cancer mortality with low-dose computed tomography (LDCT) screening (Aberle et al 2011), the US Preventive Services Task Force (USPSTF) recommended lung cancer screening for specific high-risk populations (Moyer and USPSTF, 2014), and in 2015, Medicare and private insurance began to provide coverage of LDCT screening for lung cancer. Following these policy changes, advocates, researchers, and health care providers anticipated a strong upsurge in screening rates and hoped that lung cancer screening might provide a teachable moment regarding smoking cessation (Lennes et al, 2018). However, anecdotal evidence and two recent studies (Huo et al, 2017; Jemal and Fedewa, 2017) have shown lower than expected rates of screening among individuals for whom screening is recommended based on their smoking history.…”
Section: Introductionmentioning
confidence: 99%
“…After the National Lung Screening Trial (NLST) findings in 2011 showed a substantial relative reduction in lung cancer mortality with low-dose computed tomography (LDCT) screening (Aberle et al 2011), the US Preventive Services Task Force (USPSTF) recommended lung cancer screening for specific high-risk populations (Moyer and USPSTF, 2014), and in 2015, Medicare and private insurance began to provide coverage of LDCT screening for lung cancer. Following these policy changes, advocates, researchers, and health care providers anticipated a strong upsurge in screening rates and hoped that lung cancer screening might provide a teachable moment regarding smoking cessation (Lennes et al, 2018). However, anecdotal evidence and two recent studies (Huo et al, 2017; Jemal and Fedewa, 2017) have shown lower than expected rates of screening among individuals for whom screening is recommended based on their smoking history.…”
Section: Introductionmentioning
confidence: 99%